Investor Relations Home
Investor Overview
Investor Relations Home
Corporate Strategy
Clinical Outcome Studies
Why Invest?
SmartVest® Home
Financial Information
Quarterly Results
SEC Filings
Annual Shareholder Letters
Annual Meeting
Events & Presentations
News & Media
Newsroom
Media
Stock Information
Market Data
Analyst Coverage
Corporate Governance
Management Team & Board of Directors
Committee Composition
Governance Documents
IR Services
Contact IR
Email Alerts
Investor FAQs
Glossary of Terms
Investor Overview
Financial Information
Events & Presentations
News &
Media
Stock Information
Corporate Governance
IR
Services
Investor Overview
Investor Relations Home
Corporate Strategy
Clinical Outcome Studies
Why Invest?
SmartVest® Home
Financial Information
Quarterly Results
SEC Filings
Annual Shareholder Letters
Annual Meeting
Events & Presentations
News &
Media
Newsroom
Media
Stock Information
Market Data
Analyst Coverage
Corporate Governance
Management Team & Board of Directors
Committee Composition
Governance Documents
IR
Services
Contact IR
Email Notifications
Investor FAQs
Glossary of Terms
Clinical Outcome Studies
6/27/2019
First-Of-Its-Kind Independent Study Finds SmartVest® Reduces Exacerbations, Antibiotic Use, and Stabilizes Lung Function as Part of a Treatment Algorithm (Press Release)
8/14/2018
Results of an Independent Clinical Study (Press Release)
5/18/2018
Respiratory Therapy - Spring 2018
11/30/2017
Respiratory Therapy – Winter 2017
9/30/2016
Respiratory Therapy – Fall 2016
Click the link to the right to download:
Adobe Acrobat
Copyright
2019
,
© Powered By Q4 Inc.